![]() Seneca Biopharma Seneca Biopharma (formerly NeuralStem) is a clinical-stage biopharmaceutical company. | ![]() InVivo Therapeutics InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. | ![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |||
Founding Date | Founding Date 1996 | Founding Date 2005 | Founding Date 2016 | Founding Date 2013 | Founding Date 2017 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Carlsbad, US HQ | Locations Cambridge, US HQ | Locations Redwood City, US HQ Boston, US | Locations Cambridge, US HQ Smithfield, US | Locations Watertown, US HQ Cambridge, US |
Employees | Employees 555% decrease | Employees 6 | Employees 1438% increase | Employees 17423% increase | Employees 207 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 995.9 k | Valuation ($) 116.2 m | Valuation ($) 7.5 m | Valuation ($) 3.1 b |
Financial | |||||
Net income | Net income ($16.8m) (FY, 2025) | Net income ($10.5m) (FY, 2022) | Net income ($116.8m) (FY, 2025) | Net income ($179.7m) (FY, 2022) | Net income ($311.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 75.2m | Total funding raised $ 145.6m | Total funding raised $ 245m | Total funding raised $ 197m |

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
View company
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company